Systems for evaluating and producing Tumour Targeted T cells

• Research type

  Research Study

• Full title

  Novel systems for evaluating and producing Tumour Targeting T cells. Ref: 2019-5280

• IRAS ID

  272440

• Contact name

  Adam Perriman

• Contact email

  chawp@bristol.ac.uk

• Sponsor organisation

  University of Bristol

• Duration of Study in the UK

  1 years, 2 months, 1 days

• Research summary

  We have developed an in vitro tissue culture device called the CoED, that can be used to purify tumour targeting T cells from blood.
  We hope that using the CoED we will be able to purify, activate and functionalise T cells that can then be transferred to patients to target a range of different types of cancer.
  To further these projects towards translational applications we will purify T cells from whole human blood samples in order to confirm the feasibility of translating our technology to the clinic. We will apply to the local NHS Tissue bank (NHSBT) for whole blood samples to further our research.

• REC name

  Yorkshire & The Humber - Sheffield Research Ethics Committee

• REC reference

  20/YH/0079

• Date of REC Opinion

  17 Mar 2020

• REC opinion

  Favourable Opinion